Mechanistically, ALKBH5 decreased the m6A modification of Arg-1 mRNA, thereby reducing its stability and protein expression, suggesting that ALKBH5 loss in CRC may enhance Arg-1–mediated immunosuppression and tumor progression(Figure 3). The gene discussed is ALKBH5; the disease is neoplasm.